findmyKOL
Clinical trialNCT00056472CompletedPhase 3Interventional

Study of Pharmacotherapy of Psychotic Depression

SponsorWeill Medical College of Cornell UniversityEnrollment259Major Depressive Disorder With Psychotic Features
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of Toronto

    Toronto, Ontario, Canada

United States
  • University of Massachusetts Medical School

    Worcester, Massachusetts, United States

  • Cornell University

    New York, New York, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2003
Primary completion
30 Jun 2008
Completion
30 Jun 2008
Last update posted
2 Aug 2013
Registered enrollment
259
Registry id
NCT00056472

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.